Abstract:Bacterial multi-drug resistance (MDR) is a global challenge in the fields of medicine and health,agriculture and fishery,ecology and environment.The cross-region spread of antibiotic resistance genes (ARGs) among different species is one of the main cause of bacterial MDR.However,there is no effective strategies for addressing the intensifying bacterial MDR.The CRISPR-Cas system,consisting of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR associated proteins,can targetedly degrade exogenous nucleic acids,thus exhibiting high application potential in preventing and controlling bacterial MDR caused by ARGs.This review briefly introduced the working mechanism of CRISPR-Cas systems,followed by discussing recent advances in reducing ARGs by CRISPR-Cas systems delivered through mediators (e.g.plasmids,bacteriophages and nanoparticle).Moreover,the trends of this research field were envisioned,providing a new perspective on preventing and controlling MDR.